Hong Kong Pharmaceuticals Stock News

The analysts might have been a bit too bullish on CNOOC Limited ( HKG:883 ), given that the company fell short of...

The analysts might have been a bit too bullish on Fufeng Group Limited ( HKG:546 ), given that the company fell short...

Longfor Group Holdings Limited ( HKG:960 ) missed earnings with its latest annual results, disappointing...

As you might know, Lianlian DigiTech Co., Ltd. ( HKG:2598 ) just kicked off its latest annual results with some very...

Last week, you might have seen that XD Inc. ( HKG:2400 ) released its annual result to the market. The early response...

As you might know, BYD Company Limited ( HKG:1211 ) last week released its latest annual, and things did not turn out...

The analyst covering BaTeLab Co., Ltd. ( HKG:2149 ) delivered a dose of negativity to shareholders today, by making a...

As geopolitical tensions and energy price volatility continue to shape global market sentiment, Asian small-cap stocks are navigating a complex landscape influenced by these broader economic shifts. With key indices like the S&P MidCap 400 and Russell 2000 showing resilience amid fluctuating conditions, investors are increasingly focused on identifying opportunities within small-cap segments that may offer potential value amidst uncertainty. In this environment, a good stock is often...

Earnings jump and higher dividend put Wanguo Gold Group in focus Wanguo Gold Group (SEHK:3939) has drawn fresh attention after reporting full year 2025 results, with sales and net income higher than a year earlier, alongside a proposed increase in its final ordinary dividend. See our latest analysis for Wanguo Gold Group. The latest update appears to have shifted sentiment quickly, with a 9.67% 1 day share price return and 23.61% 7 day share price return. The 1 year total shareholder return...

The analysts covering Chervon Holdings Limited ( HKG:2285 ) delivered a dose of negativity to shareholders today, by...

Amidst a backdrop of geopolitical tensions and fluctuating energy prices, Asian markets have experienced volatility as investors navigate the complexities of these global events. Despite these challenges, opportunities arise for discerning investors seeking undervalued stocks that may be trading below their intrinsic value, offering potential for growth when market conditions stabilize.

Last week, you might have seen that BYD Electronic (International) Company Limited ( HKG:285 ) released its yearly...

COSCO SHIPPING Holdings (SEHK:1919) reported full year 2025 results showing softer revenue and earnings, with sales of CNY 219.18b and net income of CNY 30.87b, shaping how investors reassess the container shipping group. See our latest analysis for COSCO SHIPPING Holdings. Despite softer revenue and earnings, COSCO SHIPPING Holdings' 1-day share price return of 1.33% and 90-day share price return of 9.16% come alongside a 1-year total shareholder return of 41.43% and very large 5-year gains,...

WEILONG Delicious Global Holdings (SEHK:9985) has drawn fresh attention after reporting full year 2025 results, with sales of CN¥7,223.76 million and net income of CN¥1,425.2 million compared to the prior year. See our latest analysis for WEILONG Delicious Global Holdings. The latest full year earnings arrived after a weak run for shareholders, with the 1 year total shareholder return at a 34.02% loss and the 30 day share price return at a 17.34% loss, while the 3 year total shareholder...

InSilico Medicine Cayman TopCo (SEHK:3696) has opened FY 2025 with first half revenue of US$27.5 million and a basic EPS loss of US$0.25, while trailing twelve month figures show revenue of US$56.2 million alongside a net loss of US$352.3 million and EPS of US$4.48 in the red. Over the recent reported periods, the company has seen revenue shift from US$59.7 million in the first half of FY 2024 to US$26.1 million in the second half and then to US$27.5 million in the first half of FY 2025. Net...

China Resources Pharmaceutical Group (SEHK:3320) has come into focus after reporting full year 2025 results and hosting its earnings call, alongside a Board proposal to lift the final cash dividend compared with 2024. See our latest analysis for China Resources Pharmaceutical Group. The earnings release and higher proposed dividend appear to have coincided with a sharp improvement in sentiment, with a 7 day share price return of 28.67% and a 30 day share price return of 25.27% helping lift...

Jinshang Bank (SEHK:2558) has put fresh numbers on the table for FY 2025, with first half revenue of C¥1.96b and basic EPS of C¥0.18 setting the tone for how the rest of the year may be judged. Over recent periods the bank has seen revenue move between C¥1.96b and C¥2.16b per half year, while basic EPS has ranged from C¥0.12 to C¥0.18. This gives you a clear view of how the income line and per share earnings have been tracking into this latest report. With a net profit margin in the low 40s...

China Risun Group (SEHK:1907) has reported FY 2025 first half revenue of C¥20.5b and basic EPS of C¥0.0066, with the latest twelve month figures showing revenue of C¥39.3b and basic EPS of C¥0.013. The company has seen revenue move from C¥25.2b in the first half of 2024 to C¥22.3b in the second half of 2024 and then to C¥20.5b in the first half of 2025. Over the same periods, basic EPS shifted from C¥0.025383 to a loss of C¥0.021219 and then to C¥0.0066, setting up an earnings story that now...

Innovent Biologics (SEHK:1801) has drawn investor attention after recent share price moves, with the stock up 7.7% over the past day and 5.5% over the past week, inviting a closer look at its current valuation. See our latest analysis for Innovent Biologics. That 7.7% 1 day share price return and 8.5% year to date share price return sit against a 1 year total shareholder return of 85.1% and a 3 year total shareholder return of 143.2%, suggesting momentum has been building over time as the...

As you might know, Jiumaojiu International Holdings Limited ( HKG:9922 ) last week released its latest annual, and...

China Conch Venture Holdings (SEHK:586) has come into focus after releasing its full year 2025 results, reporting sales of CN¥6,547.71 million and net income of CN¥2,245.14 million, alongside higher basic earnings per share. See our latest analysis for China Conch Venture Holdings. The latest full year earnings release has arrived alongside a shifting share price picture, with the stock at HK$11.95 after a 1 day share price return of 2.14% and a 7 day share price return of 8.64%. While the 90...

China Resources Gas Group (SEHK:1193) released its full year 2025 results, reporting sales of HK$97,732.61 million and net income of HK$3,546.79 million, both lower than the previous year, which helps frame the current focus of investors. See our latest analysis for China Resources Gas Group. The recent full year results, which showed lower sales and net income, appear to sit alongside weaker momentum in the share price. The 90 day share price return shows a decline of 16%, and the 1 year...

Amidst the backdrop of geopolitical tensions in the Middle East and fluctuating energy prices, Asian markets are navigating a complex landscape that influences investor sentiment across various sectors. As investors seek opportunities within this environment, penny stocks—though often considered niche—continue to attract attention for their potential to offer growth at a lower entry cost. These stocks, typically representing smaller or newer companies, can present significant value when...

As geopolitical tensions in the Middle East and volatile energy prices continue to influence global markets, Asian equities have been impacted by these developments, with investors closely watching how economies in the region navigate rising inflationary pressures. In this context, dividend stocks can offer a measure of stability and income potential, making them an attractive option for those looking to weather uncertain times while benefiting from consistent payouts.